Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review

Objective The objective was to compare the efficacy of azithromycin and clarithromycin in combination with beta-lactams to treat community-acquired pneumonia among hospitalized adults. Methods Five databases (PubMed, Google Scholar, Trip, Medline, and Clinical Key) were searched to identify randomiz...

Full description

Bibliographic Details
Main Authors: Jumana Al-Salloum, Syed Wasif Gillani, Rana Kamran Mahmood, Shabaz Mohiuddin Gulam
Format: Article
Language:English
Published: SAGE Publishing 2021-10-01
Series:Journal of International Medical Research
Online Access:https://doi.org/10.1177/03000605211049943
_version_ 1818724857178750976
author Jumana Al-Salloum
Syed Wasif Gillani
Rana Kamran Mahmood
Shabaz Mohiuddin Gulam
author_facet Jumana Al-Salloum
Syed Wasif Gillani
Rana Kamran Mahmood
Shabaz Mohiuddin Gulam
author_sort Jumana Al-Salloum
collection DOAJ
description Objective The objective was to compare the efficacy of azithromycin and clarithromycin in combination with beta-lactams to treat community-acquired pneumonia among hospitalized adults. Methods Five databases (PubMed, Google Scholar, Trip, Medline, and Clinical Key) were searched to identify randomized clinical trials with patients exposed to azithromycin or clarithromycin in combination with a beta-lactam. All articles were critically reviewed for inclusion in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results Seven clinical trials were included. The treatment success rate for azithromycin–beta-lactam after 10 to 14 days was 87.55% and that for clarithromycin–beta-lactam after 5 to 7 days of therapy was 75.42%. Streptococcus pneumoniae was commonly found in macrolide groups, with 130 and 80 isolates in the clarithromycin-based and azithromycin-based groups, respectively. The length of hospital stay was an average of 8.45 days for patients receiving a beta-lactam–azithromycin combination and 7.25 days with a beta-lactam–clarithromycin combination. Conclusion Macrolide inter-class differences were noted, with a higher clinical success rate for azithromycin-based combinations. However, a shorter length of hospital stay was achieved with a clarithromycin–beta-lactam regimen. Thus, a macrolide combined with a beta-lactam should be chosen using susceptibility data from the treating facility.
first_indexed 2024-12-17T21:33:04Z
format Article
id doaj.art-f5b57de56c8d4585a144047f1eee95cb
institution Directory Open Access Journal
issn 1473-2300
language English
last_indexed 2024-12-17T21:33:04Z
publishDate 2021-10-01
publisher SAGE Publishing
record_format Article
series Journal of International Medical Research
spelling doaj.art-f5b57de56c8d4585a144047f1eee95cb2022-12-21T21:31:50ZengSAGE PublishingJournal of International Medical Research1473-23002021-10-014910.1177/03000605211049943Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic reviewJumana Al-SalloumSyed Wasif GillaniRana Kamran MahmoodShabaz Mohiuddin GulamObjective The objective was to compare the efficacy of azithromycin and clarithromycin in combination with beta-lactams to treat community-acquired pneumonia among hospitalized adults. Methods Five databases (PubMed, Google Scholar, Trip, Medline, and Clinical Key) were searched to identify randomized clinical trials with patients exposed to azithromycin or clarithromycin in combination with a beta-lactam. All articles were critically reviewed for inclusion in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Results Seven clinical trials were included. The treatment success rate for azithromycin–beta-lactam after 10 to 14 days was 87.55% and that for clarithromycin–beta-lactam after 5 to 7 days of therapy was 75.42%. Streptococcus pneumoniae was commonly found in macrolide groups, with 130 and 80 isolates in the clarithromycin-based and azithromycin-based groups, respectively. The length of hospital stay was an average of 8.45 days for patients receiving a beta-lactam–azithromycin combination and 7.25 days with a beta-lactam–clarithromycin combination. Conclusion Macrolide inter-class differences were noted, with a higher clinical success rate for azithromycin-based combinations. However, a shorter length of hospital stay was achieved with a clarithromycin–beta-lactam regimen. Thus, a macrolide combined with a beta-lactam should be chosen using susceptibility data from the treating facility.https://doi.org/10.1177/03000605211049943
spellingShingle Jumana Al-Salloum
Syed Wasif Gillani
Rana Kamran Mahmood
Shabaz Mohiuddin Gulam
Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review
Journal of International Medical Research
title Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review
title_full Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review
title_fullStr Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review
title_full_unstemmed Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review
title_short Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review
title_sort comparative efficacy of azithromycin versus clarithromycin in combination with beta lactams to treat community acquired pneumonia in hospitalized patients a systematic review
url https://doi.org/10.1177/03000605211049943
work_keys_str_mv AT jumanaalsalloum comparativeefficacyofazithromycinversusclarithromycinincombinationwithbetalactamstotreatcommunityacquiredpneumoniainhospitalizedpatientsasystematicreview
AT syedwasifgillani comparativeefficacyofazithromycinversusclarithromycinincombinationwithbetalactamstotreatcommunityacquiredpneumoniainhospitalizedpatientsasystematicreview
AT ranakamranmahmood comparativeefficacyofazithromycinversusclarithromycinincombinationwithbetalactamstotreatcommunityacquiredpneumoniainhospitalizedpatientsasystematicreview
AT shabazmohiuddingulam comparativeefficacyofazithromycinversusclarithromycinincombinationwithbetalactamstotreatcommunityacquiredpneumoniainhospitalizedpatientsasystematicreview